JP2010534225A - 皮膚、眼および粘膜の保護機能改善用組成物を製造するためのヒアルロン酸の使用 - Google Patents
皮膚、眼および粘膜の保護機能改善用組成物を製造するためのヒアルロン酸の使用 Download PDFInfo
- Publication number
- JP2010534225A JP2010534225A JP2010517434A JP2010517434A JP2010534225A JP 2010534225 A JP2010534225 A JP 2010534225A JP 2010517434 A JP2010517434 A JP 2010517434A JP 2010517434 A JP2010517434 A JP 2010517434A JP 2010534225 A JP2010534225 A JP 2010534225A
- Authority
- JP
- Japan
- Prior art keywords
- hyaluronic acid
- skin
- cells
- composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Otolaryngology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0705349A FR2919185B1 (fr) | 2007-07-23 | 2007-07-23 | Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses |
| PCT/FR2008/000959 WO2009024677A2 (fr) | 2007-07-23 | 2008-07-04 | Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de la fonction de protection de la peau, de l'oeil et des muqueuses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010534225A true JP2010534225A (ja) | 2010-11-04 |
| JP2010534225A5 JP2010534225A5 (cg-RX-API-DMAC7.html) | 2011-08-18 |
Family
ID=39088885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010517434A Ceased JP2010534225A (ja) | 2007-07-23 | 2008-07-04 | 皮膚、眼および粘膜の保護機能改善用組成物を製造するためのヒアルロン酸の使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8895532B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2167102B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010534225A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20100059786A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101801391B (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0814446A2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2588190T3 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2919185B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009024677A2 (cg-RX-API-DMAC7.html) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013063943A (ja) * | 2011-09-16 | 2013-04-11 | China Medical Univ | 炎症を抑制するための医薬組成物、及び方法 |
| JP2015063510A (ja) * | 2013-06-28 | 2015-04-09 | キユーピー株式会社 | 肌の保湿機能向上に関わる保湿関連遺伝子発現促進剤 |
| JP2017186276A (ja) * | 2016-04-06 | 2017-10-12 | キユーピー株式会社 | アンチポリューション剤およびアンチポリューション用皮膚外用組成物 |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010003797A1 (en) * | 2008-07-09 | 2010-01-14 | Novozymes Biopharma Dk A/S | Hyaluronic acid for corneal wound healing |
| FR2963240B1 (fr) * | 2010-07-28 | 2013-03-15 | Horus Pharma | Composition a usage topique sans conservateur comprenant de l'acide hyaluronique |
| RU2624239C2 (ru) | 2011-06-03 | 2017-07-03 | Аллерган, Инк. | Составы кожного наполнителя, включая антиоксиданты |
| US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
| US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
| US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| HUE037474T2 (hu) * | 2011-07-07 | 2018-08-28 | Holy Stone Healthcare Co Ltd | Készítmény gyulladással kapcsolatban rendellenesség kezelésében és megelõzésében történõ alkalmazásra |
| CN102669681A (zh) * | 2012-06-09 | 2012-09-19 | 东莞市照燕生物科技有限公司 | 一种保护胃肠粘膜的营养保健品 |
| WO2014063735A1 (en) | 2012-10-25 | 2014-05-01 | Mdt Int'l S.A. | Mucoadhesive compositions comprising hyaluronic acid and chitosan for topical application |
| EP3328353B1 (en) | 2015-07-27 | 2024-04-10 | Mary Kay, Inc. | Topical skin formulations |
| US20210000910A1 (en) | 2019-07-03 | 2021-01-07 | Jysk Skin Solutions Pte Ltd | Topical compositions |
| WO2022236585A1 (zh) * | 2021-05-10 | 2022-11-17 | 傅毓秀 | 玻尿酸用于制备治疗肺纤维化药剂的用途 |
| TWI816119B (zh) * | 2021-05-10 | 2023-09-21 | 國立陽明交通大學 | 玻尿酸用於製備治療急性呼吸窘迫症藥劑之用途 |
| WO2022236599A1 (zh) * | 2021-05-10 | 2022-11-17 | 傅毓秀 | 玻尿酸用于制备治疗急性呼吸窘迫症药剂的用途 |
| CN115317504A (zh) * | 2021-05-10 | 2022-11-11 | 傅毓秀 | 玻尿酸用于制备治疗急性呼吸窘迫症药剂的用途 |
| EP4426317A1 (en) * | 2021-11-05 | 2024-09-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation |
| US12083204B2 (en) | 2022-06-02 | 2024-09-10 | L'oreal | Topical composition for homeostatic delivery of nitric oxide and uses thereof |
| WO2024194437A1 (en) * | 2023-03-22 | 2024-09-26 | Institut National de la Santé et de la Recherche Médicale | Use of low molecular weight hyaluronic acid for promoting ciliated cell differentiation |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166331A (en) * | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
| JPH08508973A (ja) * | 1992-04-17 | 1996-09-24 | フィディーア・ソシエタ・ペル・アチオニ | 骨形成を刺激するための低分子量ヒアルロン酸の製法 |
| JP2002519381A (ja) * | 1998-07-06 | 2002-07-02 | フィディア アドヴァンスド バイオポリマーズ ソシエタ ア レスポンサビリタ リミタータ | ヒアルロン酸およびその誘導体を含有した生体適合性および生体分解性の消化器官内潰瘍処置用組成物 |
| FR2847818A1 (fr) * | 2002-11-28 | 2004-06-04 | Agro Ind Rech S Et Dev Ard | Composition pharmaceutique a base d'acide hyaluronique |
| JP2005513106A (ja) * | 2001-12-12 | 2005-05-12 | ウーアザファルマ アールツナイミッテル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント カンパニー カーゲー | ヘパリンを保有する眼薬剤 |
| JP2006265287A (ja) * | 2005-03-22 | 2006-10-05 | Q P Corp | 低分子ヒアルロン酸および/またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4303676A (en) * | 1980-03-21 | 1981-12-01 | Balazs Endre A | Hyaluronate based compositions and cosmetic formulations containing same |
| US4517295A (en) * | 1983-02-18 | 1985-05-14 | Diagnostic, Inc. | Hyaluronic acid from bacterial culture |
| JPS59219209A (ja) * | 1983-05-28 | 1984-12-10 | Kanebo Ltd | 皮膚化粧料 |
| DE10111165A1 (de) * | 2001-03-02 | 2002-10-10 | Knoell Hans Forschung Ev | Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen |
| DE10161110A1 (de) * | 2001-12-12 | 2003-06-26 | Ursapharm Arzneimittel Gmbh | Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung |
| US7241456B2 (en) * | 2002-10-25 | 2007-07-10 | Australian Importers Ltd. | Formulations for topical delivery of bioactive substances and methods for their use |
| WO2006072243A1 (en) * | 2005-01-03 | 2006-07-13 | Novozymes Biopolymer A/S | Hyaluronic acid fraction with moisturizing and anti-wrinkle properties |
-
2007
- 2007-07-23 FR FR0705349A patent/FR2919185B1/fr active Active
-
2008
- 2008-07-04 KR KR1020107001664A patent/KR20100059786A/ko not_active Ceased
- 2008-07-04 JP JP2010517434A patent/JP2010534225A/ja not_active Ceased
- 2008-07-04 ES ES08827623.3T patent/ES2588190T3/es active Active
- 2008-07-04 BR BRPI0814446-0A2A patent/BRPI0814446A2/pt not_active IP Right Cessation
- 2008-07-04 WO PCT/FR2008/000959 patent/WO2009024677A2/fr not_active Ceased
- 2008-07-04 EP EP08827623.3A patent/EP2167102B1/fr active Active
- 2008-07-04 US US12/670,219 patent/US8895532B2/en active Active
- 2008-07-04 CN CN2008801063138A patent/CN101801391B/zh not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166331A (en) * | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
| JPH08508973A (ja) * | 1992-04-17 | 1996-09-24 | フィディーア・ソシエタ・ペル・アチオニ | 骨形成を刺激するための低分子量ヒアルロン酸の製法 |
| JP2002519381A (ja) * | 1998-07-06 | 2002-07-02 | フィディア アドヴァンスド バイオポリマーズ ソシエタ ア レスポンサビリタ リミタータ | ヒアルロン酸およびその誘導体を含有した生体適合性および生体分解性の消化器官内潰瘍処置用組成物 |
| JP2005513106A (ja) * | 2001-12-12 | 2005-05-12 | ウーアザファルマ アールツナイミッテル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント カンパニー カーゲー | ヘパリンを保有する眼薬剤 |
| FR2847818A1 (fr) * | 2002-11-28 | 2004-06-04 | Agro Ind Rech S Et Dev Ard | Composition pharmaceutique a base d'acide hyaluronique |
| JP2006265287A (ja) * | 2005-03-22 | 2006-10-05 | Q P Corp | 低分子ヒアルロン酸および/またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013063943A (ja) * | 2011-09-16 | 2013-04-11 | China Medical Univ | 炎症を抑制するための医薬組成物、及び方法 |
| US8835405B2 (en) | 2011-09-16 | 2014-09-16 | China Medical University | Inhibiting arthritis via injection of synergistic combination of hyaluronic acid and vitamin C and/or vitamin E |
| JP2015063510A (ja) * | 2013-06-28 | 2015-04-09 | キユーピー株式会社 | 肌の保湿機能向上に関わる保湿関連遺伝子発現促進剤 |
| JP2017186276A (ja) * | 2016-04-06 | 2017-10-12 | キユーピー株式会社 | アンチポリューション剤およびアンチポリューション用皮膚外用組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| US8895532B2 (en) | 2014-11-25 |
| CN101801391A (zh) | 2010-08-11 |
| HK1145149A1 (en) | 2011-04-08 |
| WO2009024677A3 (fr) | 2009-12-03 |
| BRPI0814446A2 (pt) | 2015-01-06 |
| FR2919185B1 (fr) | 2010-09-10 |
| ES2588190T3 (es) | 2016-10-31 |
| EP2167102B1 (fr) | 2016-05-25 |
| KR20100059786A (ko) | 2010-06-04 |
| EP2167102A2 (fr) | 2010-03-31 |
| CN101801391B (zh) | 2013-07-10 |
| US20100210585A1 (en) | 2010-08-19 |
| FR2919185A1 (fr) | 2009-01-30 |
| WO2009024677A2 (fr) | 2009-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8895532B2 (en) | Use of hyaluronic acid for the preparation of compositions intended for improving in particular the protective function of the skin, the eye and the mucous membranes | |
| EP1461031B1 (en) | Formulations for oral administration of cromolyn sodium | |
| JP6505594B2 (ja) | プロバイオティクス細菌 | |
| CN110139662A (zh) | 肽的抗炎用途 | |
| RU2011126239A (ru) | Фармацевтическая композиция, составленная для локального нанесения на поверхность барьера эпителиальной ткани, содержащая антитела, которые проходят через этот барьер | |
| TWI913236B (zh) | 新多功能寡肽 | |
| CN107619437B (zh) | 一种皮肤创伤修复肽whpp-oa1及其提纯方法与应用 | |
| KR20220079860A (ko) | 신규 펩티드 | |
| CN118178459B (zh) | 阿拉伯木聚糖在制备治疗肺纤维化药物中的应用 | |
| CN101766647A (zh) | 蒙脱石在治疗过敏性鼻炎和皮肤过敏上的用途 | |
| HK1145149B (en) | Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection | |
| TWI480044B (zh) | A high molecular weight heparin or low molecular weight heparin for the preparation of a composition for at least two consecutive days of administration to improve the allergic constitution | |
| CN110870862A (zh) | 岩白菜素在制备治疗体内肺炎克雷伯氏菌感染药物中的用途 | |
| CN112220740B (zh) | 一种鼻炎预防或治疗用抗菌消炎微凝胶及其制备方法和应用 | |
| CN115518079A (zh) | 一种益生菌及其外膜囊泡在制备防治支气管哮喘制剂中的应用 | |
| WO2000069917A1 (fr) | Compositions medicinales destinees a inhiber le systeme kallikreine-kinine ou la phospholipase a¿2? | |
| CN118236413B (zh) | 一种能中和细菌毒素的蒲公英提取物及其应用 | |
| RU2191024C1 (ru) | Ингаляционный препарат, купирующий удушье при бронхиальной астме и бронхоспазме | |
| CN101011417A (zh) | 一种治疗慢性阻塞性肺病的糖蛋白 | |
| Qiu et al. | Nrf2 Improves Airway Goblet Cell Metaplasia in Chronic Obstructive Pulmonary Disease (COPD) and Its Mechanism | |
| Schachter et al. | Hyperresponsiveness to tobacco dust extract in sensitized guinea pig trachea | |
| CN105998086A (zh) | 一种预防和治疗气道炎症的微藻组合物及其制剂和应用 | |
| JP2026048594A (ja) | 気道疾患の治療または予防のためのバクテリアセルロースの使用 | |
| WO2025101524A1 (en) | Lipopeptide compounds, and use in modulating eosinophilia | |
| Cliffton et al. | Management of pulmonary complications of surgical operations (primarily atelectasis) with pancreatic dornase inhalations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110630 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110630 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130326 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130625 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130702 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130712 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20131126 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140326 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140327 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20140527 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20140704 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20141008 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151022 |
|
| A045 | Written measure of dismissal of application [lapsed due to lack of payment] |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20160426 |